CL2017002796A1 - Una composición farmacéutica antiviral de uso tópico. - Google Patents
Una composición farmacéutica antiviral de uso tópico.Info
- Publication number
- CL2017002796A1 CL2017002796A1 CL2017002796A CL2017002796A CL2017002796A1 CL 2017002796 A1 CL2017002796 A1 CL 2017002796A1 CL 2017002796 A CL2017002796 A CL 2017002796A CL 2017002796 A CL2017002796 A CL 2017002796A CL 2017002796 A1 CL2017002796 A1 CL 2017002796A1
- Authority
- CL
- Chile
- Prior art keywords
- pharmaceutical composition
- antiviral pharmaceutical
- topical antiviral
- conditional
- topical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/74—Synthetic polymeric materials
- A61K31/765—Polymers containing oxygen
- A61K31/78—Polymers containing oxygen of acrylic acid or derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
- A61K31/165—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide
- A61K31/167—Amides, e.g. hydroxamic acids having aromatic rings, e.g. colchicine, atenolol, progabide having the nitrogen of a carboxamide group directly attached to the aromatic ring, e.g. lidocaine, paracetamol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
- A61K31/4425—Pyridinium derivatives, e.g. pralidoxime, pyridostigmine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
Abstract
<p>UNA COMPOSICIÓN FARMACÉUTICA ANTIVIRAL DE USO TÓPICO CONTRA AQUELLOS VIRUS CON ENVOLTURA LIPÍDICA, QUE COMPRENDE COMO PRINCIPIOS ACTIVOS UN COPOLÍMERO CATIÓNICO 5 CONTENIENDO GRUPOS AMINOS TERCIARIOS, Y UN TENSIOACTIVO CATIÓNICO CONTENIENDO GRUPOS AMONIOS CUATERNARIOS.</p>
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ARP150101519A AR100459A1 (es) | 2015-05-15 | 2015-05-15 | Una composición farmacéutica antiviral de uso tópico |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2017002796A1 true CL2017002796A1 (es) | 2018-07-13 |
Family
ID=57319498
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2017002796A CL2017002796A1 (es) | 2015-05-15 | 2017-11-06 | Una composición farmacéutica antiviral de uso tópico. |
Country Status (11)
Country | Link |
---|---|
US (1) | US10478452B2 (es) |
EP (1) | EP3295934B1 (es) |
AR (1) | AR100459A1 (es) |
BR (1) | BR112017024399B1 (es) |
CL (1) | CL2017002796A1 (es) |
CO (1) | CO2017011297A2 (es) |
ES (1) | ES2915824T3 (es) |
IL (1) | IL255635A (es) |
MX (1) | MX2017014162A (es) |
PE (1) | PE20180396A1 (es) |
WO (1) | WO2016185069A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2022219944A1 (ja) * | 2021-04-16 | 2022-10-20 | 株式会社日本触媒 | 抗コロナウイルス剤 |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3743727A (en) * | 1970-11-16 | 1973-07-03 | Crown Zellerbach Corp | Enhancing tissue penetration of certain antimicrobial agents with dimethyl sulfoxide |
US4902720A (en) * | 1983-01-10 | 1990-02-20 | Baldone Joseph A | Treatment of virus infections with quaternary ammonium compounds |
US5160737A (en) * | 1988-05-03 | 1992-11-03 | Perio Products Ltd. | Liquid polymer composition, and method of use |
BRPI0014271B1 (pt) * | 1999-09-24 | 2021-06-22 | Janssen Pharmaceutica N.V. | Partícula consistindo em uma dispersão de sólidos, uso da dita partícula, dispersão de sólidos, forma de dosagem farmacêutica, bem como processos de preparação de dita partícula, dispersão e forma de dosagem |
US6855341B2 (en) | 2002-11-04 | 2005-02-15 | Jeffrey B. Smith | Anti-viral compositions and methods of making and using the anti-viral compositions |
US7968122B2 (en) * | 2003-12-10 | 2011-06-28 | Adventrx Pharmaceuticals, Inc. | Anti-viral pharmaceutical compositions |
ITMI20051417A1 (it) * | 2005-07-22 | 2007-01-23 | Mipharm S P A | Formulazione topica in forma di gel contenente come ingredienti attivi ciclovit e lidocaina |
US8119115B2 (en) * | 2006-02-09 | 2012-02-21 | Gojo Industries, Inc. | Antiviral method |
US7883487B2 (en) * | 2008-06-16 | 2011-02-08 | Shantha Totada R | Transdermal local anesthetic patch with injection port |
US20140328895A1 (en) * | 2011-03-29 | 2014-11-06 | Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. | Film-forming composition for a ph-dependant sustained release of the active agent |
-
2015
- 2015-05-15 AR ARP150101519A patent/AR100459A1/es unknown
-
2016
- 2016-05-13 PE PE2017002343A patent/PE20180396A1/es unknown
- 2016-05-13 EP EP16795937.8A patent/EP3295934B1/en active Active
- 2016-05-13 BR BR112017024399-7A patent/BR112017024399B1/pt active IP Right Grant
- 2016-05-13 ES ES16795937T patent/ES2915824T3/es active Active
- 2016-05-13 WO PCT/ES2016/070365 patent/WO2016185069A1/es active Application Filing
- 2016-05-13 MX MX2017014162A patent/MX2017014162A/es unknown
- 2016-05-13 US US15/573,901 patent/US10478452B2/en active Active
-
2017
- 2017-11-02 CO CONC2017/0011297A patent/CO2017011297A2/es unknown
- 2017-11-06 CL CL2017002796A patent/CL2017002796A1/es unknown
- 2017-11-13 IL IL255635A patent/IL255635A/en unknown
Also Published As
Publication number | Publication date |
---|---|
MX2017014162A (es) | 2018-06-20 |
WO2016185069A1 (es) | 2016-11-24 |
US20180250327A1 (en) | 2018-09-06 |
CO2017011297A2 (es) | 2018-01-31 |
BR112017024399A2 (pt) | 2019-02-05 |
IL255635A (en) | 2018-01-31 |
EP3295934A1 (en) | 2018-03-21 |
EP3295934B1 (en) | 2022-03-02 |
ES2915824T3 (es) | 2022-06-27 |
EP3295934A4 (en) | 2019-01-02 |
BR112017024399B1 (pt) | 2022-06-07 |
AR100459A1 (es) | 2016-10-05 |
PE20180396A1 (es) | 2018-02-28 |
US10478452B2 (en) | 2019-11-19 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2016002269A1 (es) | Moduladores alostéricos del núcleo proteico de la hepatitis b. | |
CO2017001994A2 (es) | Compuestos activos hacia bromodominios | |
CL2016000381A1 (es) | Compuestos antivirales | |
CL2015003615A1 (es) | Nucleósidos sustituidos, nucleótidos y análogos de los mismos. | |
BR112015009189A2 (pt) | conjunto de potência para um autoinjetor e autoinjetor que contém o mesmo | |
CL2014000956A1 (es) | Compuestos derivados de (4-fenilimidazol-2-il)etilamina, como moduladores de canal de sodio; composicion farmaceutica que los comprende; y su uso en el tratamiento del dolor. | |
BR112018003110A2 (pt) | nanopartículas terapêuticas compreendendo um agente terapêutico e métodos de fabricação e uso dos mesmos | |
GT201500020A (es) | Sulfamoilarilamidas y su uso como medicamentos para el tratamiento de la hepatitis b | |
CU20160187A7 (es) | (2r,5s,13ar)-7,9-dioxo-10-((2,4,6-trifluorobencil)carbamoil)-2,3,4,5,7,9,13, 13a-octahidro-2,5-metanopirido[1',2':4,5]pirazino[2,1-b][1,3]oxazepin-8-olato de sodio | |
BR112018011122A2 (pt) | antígenos, vetores, composições, e métodos de utilização para o vírus da imunodeficiência humana dos mesmos | |
BR112015027321A8 (pt) | Compostos e composições para modular a expressão de apolipoproteína(a) e seus usos | |
BR112015018161A2 (pt) | Conjugado de oligômeros antisense de lna, composição farmacêutica e uso de um conjugado de oligômeros antisense de lna | |
BR112016026291A2 (pt) | Derivados do ácido borônico e usos terapêuticos dos mesmos | |
CL2016001973A1 (es) | Derivados de nucleosido sustituidos con 4' -difluorometilo como inhibidores de la replicación de arn de la influenza. | |
BR112019000693A2 (pt) | composições de muc1- car e métodos para uso | |
BR112018002983A2 (pt) | composição compreendendo uma lactama e um álcool | |
BR112015000520A2 (pt) | agente de espessamento estável com lipase | |
BR112016006048A8 (pt) | composições antimicrobianas | |
CL2016002835A1 (es) | “compuestos derivados de pladienolida con un resto piridinico; composición farmacéutica que los comprende; y su uso en el tratamiento del cáncer”. pct | |
EP3878445A3 (en) | Acamprosate formulations, methods of using the same, and combinations comprising the same | |
EA201590805A1 (ru) | Композиция с немедленным и пролонгированным высвобождением | |
CL2017000394A1 (es) | Composición que contiene cineol para la administración nasal | |
MX2017009812A (es) | Composiciones y metodos para inhibir infeccion viral. | |
BR112014025416A2 (pt) | AGENTES ANTIMALÁRICOS, COMPOSIÇÃO FARMACEUTICA COMPREENDENDO-OS E USO Dos MESMOS. | |
CR20150145A (es) | Composiciones con matriz de resina fundida en caliente |